This content is machine translated Blood products Transfusions and haemovigilance In Switzerland, approximately 300,000 labile blood products are transfused per year. Approximately ten adverse events per 1000 transfusions are reported. With increasing knowledge of the individual transfusion reactions, the number…
View Post 7 min This content is machine translated Red blood cell concentrates and erythropoiesis-stimulating agents Blood transfusions in oncology – when and for whom? In tumor patients, treatable causes of anemia should also be deliberately sought before transfusion. No transfusion due to falling below a “transfusion trigger”: The indication for a transfusion should always…
